Cliff Asness’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Cliff Asness’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,667	Closed	-$873K	–	2296
2015 Q4	$873K	Sell	2,667 -321	-11%	-$104K	﹤0.01%	1634
2015 Q3	$964K	Sell	2,988 -594	-17%	-$261K	﹤0.01%	1448
2015 Q2	$1.43M	Buy	3,582 +1,659	+86%	+$705K	﹤0.01%	1334
2015 Q1	$947K	Sell	1,923 -922	-32%	-$357K	﹤0.01%	1439
2014 Q4	$1.02M	Sell	2,845 -412	-13%	-$123K	﹤0.01%	1636
2014 Q3	$628K	Sell	3,257 -1,222	-27%	-$269K	﹤0.01%	1848
2014 Q2	$1.07M	Buy	4,479 +134	+3%	+$27.2K	﹤0.01%	1613
2014 Q1	$1.11M	Buy	+4,345	New	+$1.33M	﹤0.01%	1654

Other funds holding LUMO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cliff Asness's LUMO Position: Q1 2016 in Review

Cliff Asness sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2016, closing a stake of 2,667 shares — an estimated $873K sold.

Cliff Asness first reported a position in LUMO in Q1 2014 and held it in 8 quarters. The position peaked at $1.43M in Q2 2015. 139 funds tracked by Wall St. Rank hold LUMO as of Q1 2016.

Cliff Asness reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Cliff Asness sold 2,667 Lumos Pharma, Inc. Common Stock shares in Q1 2016, an estimated $873K.
Cliff Asness first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 8 quarters.
Cliff Asness's Lumos Pharma, Inc. Common Stock position peaked at $1.43M in Q2 2015.
139 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2016.

Based on AQR Capital Management's 13F filing for Q1 2016, filed 16 May 2016.